Aaron Deese is a Midlothian, Virginia based male Optometrist who is specialized in Optometry. Active license number of Aaron Deese is 0618003447 for Optometry in Virginia. Aaron Deese examine, diagnose, treat, and manage diseases, injuries, and disorders of the visual system, the eye, and associated structures as well as identify related systemic conditions affecting the eye. He completed pre-professional undergraduate education in a college or university and four years of professional education at a college of optometry, leading to the doctor of optometry (O.D.) degree. He is a eye health care professional who is state-licensed to diagnose and treat diseases and disorders of the eye and visual system.
Complete Profile:
Aaron Deese speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1861222440
NPI Enumeration Date:
07 Aug, 2024
NPI Last Update On:
07 Aug, 2024
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Aaron Deese are as mentioned below.
License Number
Specialization
State
Status
0618003447
Optometry
Virginia
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
14431 Sommerville Ct Ste B, Midlothian, Virginia
Zip:
23113-6812
Phone Number:
804-888-8998
Fax Number:
--
Patients can reach Aaron Deese at 14431 Sommerville Ct Ste B, Midlothian, Virginia or can call to book an appointment on 804-888-8998. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 12 August, 2024.